Tafenoquine and G6PD: a primer for clinicians
BACKGROUND:Tafenoquine, an 8-aminoquinoline, is now indicated for causal prophylaxis against all human malarias and as radical curative (anti-relapse) treatment against Plasmodium vivax and Plasmodium ovale. As with other 8-aminoquinolines tafenoquine causes hemolysis in individuals with glucose-6-p...
| 主要な著者: | , |
|---|---|
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
Oxford University Press
2019
|